Mediclinic International

Mediclinic International plc, founded in 1983, is an international private hospital group with operations in South Africa, Namibia, Switzerland and the United Arab Emirates. The Group's head office is based in Stellenbosch, South Africa. It has been listed on the JSE, the South African securities exchange, since 1986. It is also listed on the London Stock Exchange and its is a constituent of the FTSE 250 Index.

Mediclinic International plc
TypePublic limited company
LSE: MDC
JSE: MEI
IndustryHospital management
FoundedOctober 3, 1983 (1983-10-03)
Headquarters
Stellenbosch, South Africa
Key people
Dr Edwin Hertzog (Chairman)
Dr Ronnie van der Merwe(CEO)
Revenue£2,932 million (2019)[1]
£81 million (2019)[1]
£(130) million (2019)[1]
Number of employees
32,398 (2019)[1]
Websitewww.mediclinic.com

History

Mediclinic International was founded in 1983 in Stellenbosch, South Africa when its current chairman, Dr Edwin Hertzog, was commissioned by the then Rembrandt Group (now Remgro Group) to undertake a feasibility study on how profitable private hospitals could be. Three years later Mediclinic International, running four hospitals in commission and three hospitals under construction, listed on the JSE, the South African stock exchange in 1986.[2]

Mediclinic Africa Head Office in Stellenbosch, South Africa.

In 2006, Mediclinic reached agreement to acquire a controlling interest in Emirates Healthcare in Dubai, United Arab Emirates, which then owned one hospital, the rights to develop two further hospitals in the Dubai Healthcare City and five clinics.[3]

Mediclinic acquired Hirslanden, the largest private hospital group in Switzerland, for SF2.54bn in 2007.[3]

In June 2015, Mediclinic then acquired a 29.9% interest in Spire Healthcare, a UK-based private healthcare group.[4]

Mediclinic announced a reverse merger of Al Noor Hospitals in October 2015.[5] The former Mediclinic shareholders owned up to 93% of the combined business on completion.[5] The merger was completed on 15 February 2016.[6]

The healthcare group officially started trading on the London Stock Exchange on 16 February 2016.[7]

The South African arm of Mediclinic was criticised in 2021 when it emerged that controversial doctor Wouter Basson was working at one of its Western Cape facilties.[8]

Operations

Mediclinic also holds a 29.9% interest in Spire Healthcare, a LSE listed and UK-based private healthcare group.[2]

References
  1. "Annual Results 2019". Mediclinic International. Retrieved 2 January 2020.
  2. "Mediclinic gains from R29bn refinancing". Financial Mail. 11 September 2012. Retrieved 3 February 2016.
  3. Reuters Editorial (2 August 2007). "Medi-Clinic to buy Swiss hospitals for $2.36 bln". Reuters UK. Retrieved 16 February 2016.
  4. "Spire Healthcare sells 29.9pc stake to Johannesburg rival". Telegraph.co.uk. 22 June 2015. Retrieved 16 February 2016.
  5. "Mediclinic International and Gulf group Al Noor agree on tie-up". Business Day Live. 14 October 2015. Retrieved 3 February 2016.
  6. "Al Noor Hospitals completes merger with Mediclinic". Digital Look. 15 February 2016. Retrieved 15 February 2016.
  7. "Merged Al Noor/Mediclinic to list on Feb 15, eyes Gulf expansion". Reuters. 16 February 2016.
  8. Head, Tom (19 January 2021). "Wouter Basson, apartheid's 'Dr. Death', revealed to be working at a Mediclinic". The South African. Retrieved 19 January 2021.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.